US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen

Congressional oversight agency urges FDA to make better use of foreign offices with more effective performance measures and staffing goals; GAO notes agency’s progress towards risk-based inspections – and its plan to revisit every site at least once every five years.

More from Manufacturing

More from Compliance